Stock screener

KPTI

Conviction 100HealthcareScan · Fri, Jun 26, 2026
KPTI$10.20+7.82%
ResistanceSupportVol 14Insider sell
63 bars
6
Vol MA14 428.92K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Karyopharm Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.karyopharm.com
Price10.20
Change+7.82%
Gap-0.74%
Rel volume3.48×
Avg volume409.54K
Avg $ vol3.84M
SMA 209.23
SMA 508.88
SMA 2007.35
Price vs 50+14.86%
Price vs 200+38.80%
MA stackbullish
50/200 cross
Supertrendup · 7.56
RSI (14)62
MACD hist0.05
MACD crossbull · 1d
Stoch %K / %D98 / 65
ADX (14)31
+DI / −DI30 / 10
RSI divergence
MACD divergence
ATR %+7.30%
ADR %7.89%
52w high10.20
52w low3.77
From 52w high+0.00%
Above 52w low+170.56%
New 52w highYes
SqueezeOn · 7d
Bollinger width16.56%
%B1.13
Donchian pos97.79%
Donchian high10.24
Donchian low8.43
AVWAP (52w high)7.45
vs AVWAP high+36.88%
AVWAP (52w low)7.27
vs AVWAP low+40.28%
OBV trendUp
Chaikin MF (20)0.15
Today vs 20d3.48×
Avg vol (14d)428.92K
Avg vol (20d)409.54K
Avg $ vol (20d)3.84M
Market cap
RS 3m (vs SPY)+69.78%
RS 6m (vs SPY)+22.90%
RS line new highNo
Trend template8/8
Technical rank89.4
1 week+13.08%
1 month+13.59%
3 months+83.12%
6 months+37.10%
1 year+127.17%
YTD+41.86%
P/E-1.09
P/B-0.81
P/S1.47
P/FCF-2.84
EPS-17.93
Div yield
ROE73.80%
ROA-149.17%
Debt/Eq-0.64
Current1.08
EV/EBITDA-3.26
Gross margin
Net margin-134.21%
Rev growth0.57%
EPS growth-156.52%
Price target
Target upside
Analyst rating
Institutional
Ent. value292.49M
Revenue35.07M
Net income-22.39M
Gross profit
Free cash flow-75.37M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out
Employees228
ListedWed, Nov 6, 2013
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA+
Conviction100 / 100
Pattern quality
Tech rank89.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance10.22
Support7.64
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KPTI

All disclosures →
No recent disclosed trades by Congress in KPTI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KPTI · 6 buys · 4 sells

InsiderSideShares
PAKIANATHAN DEEPIKA
Director · Common Stock · 2026-05-21
Grant15.51K
Su Zhen
Director · Common Stock · 2026-05-21
Grant15.51K
Schor Chen
Director · Common Stock · 2026-05-21
Grant15.51K
Greene Barry E
Director · Common Stock · 2026-05-21
Grant15.51K
Oliger Christy J.
Director · Common Stock · 2026-05-21
Grant15.51K
BOHLIN GAREN G
Director · Common Stock · 2026-05-21
Grant15.51K
Poulton Stuart
EVP, Chief Development Officer · Common Stock · 2026-05-14
Sell403
Cheng Sohanya Roshan
EVP & Chief Commercial Officer · Common Stock · 2026-05-14
Sell324
Paulson Richard A.
President and CEO · Common Stock · 2026-05-14
Sell2.2K
Abate Kristin
Chief Accounting Officer · Common Stock · 2026-05-14
Sell53

SEC filings

EDGAR filings in KPTI · 1 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.